Evolus Inc
For the period ended Dec 31, 2024. Filed Mar 4, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 4, 2025
EOLS$6.81-2.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(in thousands, except par value and share data)
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | $86,952 | $62,838 |
| Accounts receivable, net | 47,682 | 30,529 |
| Inventories | 12,158 | 10,998 |
| Prepaid expenses | 3,349 | 5,700 |
| Other current assets | 1,201 | 2,356 |
| Total current assets | 151,342 | 112,421 |
| Property and equipment, net | 3,222 | 2,087 |
| Operating lease right-of-use assets | 7,185 | 5,763 |
| Intangible assets, net | 48,754 | 47,110 |
| Goodwill | 21,208 | 21,208 |
| Other assets | 858 | 409 |
| Total assets | $232,569 | $188,998 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||
| Current Liabilities | ||
| Accounts payable | $9,236 | $4,271 |
| Accrued expenses | 40,791 | 33,813 |
| Operating lease liabilities | 1,718 | 1,377 |
| Contingent royalty obligation payable to Evolus Founders | 11,215 | 8,830 |
| Total current liabilities | 62,960 | 48,291 |
| Operating lease liabilities | 6,755 | 4,810 |
| Contingent royalty obligation payable to Evolus Founders | 33,550 | 36,200 |
| Term loan, net of discount and issuance costs | 121,506 | 120,359 |
| Contingent milestone payment | 2,270 | — |
| Deferred tax liability | 6 | 27 |
| Total liabilities | $227,047 | $209,687 |
| Commitments and contingencies (Note 9) | ||
| Stockholders’ equity (deficit) | ||
| Preferred Stock, $0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at December 31, 2024 and 2023, respectively | — | — |
| Common Stock, $0.00001 par value; 100,000,000 shares authorized; 63,497,548 and 57,820,621 shares issued and outstanding at December 31, 2024 and 2023, respectively | 1 | 1 |
| Additional paid-in capital | 615,825 | 538,716 |
| Accumulated other comprehensive loss | (905) | (427) |
| Accumulated deficit | (609,399) | (558,979) |
| Total stockholders’ equity (deficit) | 5,522 | (20,689) |
| Total liabilities and stockholders’ equity (deficit) | $232,569 | $188,998 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.